Felix Guerrero-Ramos

Profesor

Universidad CEU San Pablo

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Felix Guerrero-Ramos is a Professor at Universidad CEU San Pablo, Spain. His research focuses on the treatment and understanding of bladder cancer, specifically in areas such as perioperative treatment, non-muscle-invasive bladder cancer, and renal function post-nephrectomy. He has authored several recent articles that contribute to the evolving landscape of cancer therapies and the implications for patient care.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Jesús González de la Aleja

SPAIN

View details

Celeste Manfredi

University of Campania “Luigi Vanvitelli”

ITALY

View details

Sandra Nunes

Instituto Português de Oncologia do Porto

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Felix Guerrero-Ramos

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

The Dynamic Field of Perioperative Treatment for Localized Muscle-Invasive Bladder Cancer: A Review of the Current Research Landscape

TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC

Correction: González-Ginel et al. Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy. J. Clin. Med. 2024, 13, 6305

Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery

Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non-muscle-invasive Bladder Cancer.

Multidisciplinary consensus document on the current treatment of bacille Calmette-Guérin-unresponsive non-muscle invasive bladder tumor.

Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs

Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

Epidemiology, Diagnosis and Management of Penile Cancer: Results from the Spanish National Registry of Penile Cancer

Extrauterine Retroperitoneal Leiomyomas: 3 Case Reports and Review of the Literature

Immune Predictors of Response after Bacillus Calmette–Guérin Treatment in Non-Muscle-Invasive Bladder Cancer

BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?

Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain

Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis.

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future.

Collaborators (3)

Jesús González de la Aleja

Celeste Manfredi

Sandra Nunes

Make your next move.

Felix Guerrero-Ramos

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

The Dynamic Field of Perioperative Treatment for Localized Muscle-Invasive Bladder Cancer: A Review of the Current Research Landscape

TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC

Correction: González-Ginel et al. Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy. J. Clin. Med. 2024, 13, 6305

Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery

Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non-muscle-invasive Bladder Cancer.

Multidisciplinary consensus document on the current treatment of bacille Calmette-Guérin-unresponsive non-muscle invasive bladder tumor.

Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs

Organ-Sparing Surgery for Testicular Germ Cell Tumors: A Current Perspective

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

Epidemiology, Diagnosis and Management of Penile Cancer: Results from the Spanish National Registry of Penile Cancer

Extrauterine Retroperitoneal Leiomyomas: 3 Case Reports and Review of the Literature

Immune Predictors of Response after Bacillus Calmette–Guérin Treatment in Non-Muscle-Invasive Bladder Cancer

BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?

Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells&rsquo; Pluripotency in Bladder Cancer

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain

Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis.

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future.

Collaborators (3)

Jesús González de la Aleja

Celeste Manfredi

Sandra Nunes

Make your next move.

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells’ Pluripotency in Bladder Cancer